Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

CD40 activation of B-CLL cells is associated with augmented intracellular levels of CD79b and increased BCR expression in a subset of patients

Leukemia volume 19, pages 1099–1101 (2005)Cite this article

TO THE EDITOR

Many studies have reported the surface immunophenotypic analysis of B-CLL cells, identifying reduced BCR expression as an hallmark of this disease;1 yet, the intracellular expression of Ig, CD79a, and CD79b has been less carefully evaluated. Since different mechanistic explanations have been proposed for this phenomenon, including (i) somatic mutations of the B29 gene,2 (ii) overexpression of a product of alternative splicing of CD79b,3 or (iii) a defect in the transport of normally synthesized BCR components to the cell surface;4 and surface analysis cannot discern between these possibilities, we performed a thorough analysis of surface and intracellular expression of all BCR components in B-CLL cells (Indraccolo S et al, in preparation). We found a heterogeneous pattern of expression of the BCR components in 22 B-CLL samples studied, ranging from those whose phenotype was similar to normal B cells (2/22), to others which almost lacked intracellular IgM expression (3/22). The relative majority of the B-CLL samples (17/22), however, presented with a sort of dichotomy in the surface and intracellular expression levels of the BCR molecules; intracellular staining was considerably stronger than membrane-associated reactivity (not shown). Interestingly, in about one-third of these samples (9/22), low-level intracellular reactivity was detected principally for CD79b.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Caligaris-Cappio F . B-chronic lymphocytic leukemia: a malignancy of anti-self B cells. Blood 1996; 87: 2615–2620.

    CAS  PubMed  Google Scholar 

  2. Thompson AA, Talley JA, Do HN, Kagan HL, Kunkel L, Berenson J et al Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia. Blood 1997; 90: 1387–1394.

    CAS  PubMed  Google Scholar 

  3. Alfarano A, Indraccolo S, Circosta P, Minuzzo S, Vallario A, Zamarchi R et al An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia. Blood 1999; 93: 2327–2335.

    CAS  PubMed  Google Scholar 

  4. Payelle-Brogard B, Magnac C, Alcover A, Roux P, Dighiero G . Defective assembly of the B-cell receptor chains accounts for its low expression in B-chronic lymphocytic leukaemia. Br J Haematol 2002; 118: 976–985.

    Article  CAS  PubMed  Google Scholar 

  5. Gricks CS, Zahrieh D, Zauls AJ, Gorgun G, Drandi D, Mauerer K et al Differential regulation of gene expression following CD40 activation of leukemic compared to healthy B cells. Blood 2004; 104: 4002–4009.

    Article  CAS  PubMed  Google Scholar 

  6. Payelle-Brogard B, Magnac C, Oppezzo P, Dumas G, Dighiero G, Vuillier F . Retention and defective assembly of the B-cell receptor in the endoplasmic reticulum of chronic lymphocytic leukaemia B cells cannot be reverted upon CD40 ligand stimulation. Leukemia 2003; 17: 1196–1199.

    Article  CAS  PubMed  Google Scholar 

  7. Granziero L, Ghia P, Circosta P, Gottardi D, Strola G, Geuna M et al Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood 2001; 97: 2777–2783.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by AIRC (Associazione Italiana per la Ricerca sul Cancro), FIRC (Fondazione Italiana per la Ricerca sul Cancro), Ministero dell’Università e Ricerca Scientifica (MIUR 60%, PRIN and FIRB), ISS-AIDS Project. VT is a recipient of an AIRC fellowship. The invaluable help of P Gallo in artwork preparation is gratefully acknowledged.

Author information

Author notes

  1. S Minuzzo and S Indraccolo: These two authors contributed equally to this work.

Authors and Affiliations

  1. Department of Oncology and Surgical Sciences, University of Padova, Padova, Italy

    S Minuzzo, S Indraccolo, V Tosello, E Piovan & A Amadori

  2. Azienda Ospedaliera, Padova, Italy

    S Indraccolo

  3. VIMM & Department of Clinical and Experimental Medicine, Clinical Immunology Branch, University of Padova, Padova, Italy

    A Cabrelle, L Trentin & G Semenzato

Authors
  1. S Minuzzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Indraccolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V Tosello
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E Piovan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A Cabrelle
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L Trentin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G Semenzato
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A Amadori
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S Indraccolo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Minuzzo, S., Indraccolo, S., Tosello, V. et al. CD40 activation of B-CLL cells is associated with augmented intracellular levels of CD79b and increased BCR expression in a subset of patients. Leukemia 19, 1099–1101 (2005). https://doi.org/10.1038/sj.leu.2403772

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403772

This article is cited by

Search

Advanced search

Quick links